Xbrane Biopharma | Sustainability Performance
Xbrane Biopharma AB focuses on the development of biologic drugs, particularly in the area of biosimilars. The company aims to address unmet medical needs through its research and development initiatives in pharmaceuticals.
2008
Sweden
51 - 200 employees
Biotechnology
$10M - 25M in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#1964
Overallⓘ#159
in Swedenⓘ#28
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon certificatesDigital emissionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Xbrane Biopharma reported sustained losses during biosimilar development with material going-concern uncertainty.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
2-3
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.